PMC Links for Gene (Select 11126) - PMC

Links from Gene

Items: 1 to 20 of 28

<< First< Prev

Page of 2

Select item 103230811.

Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer

Jiatao Liao, Hongyan Lai, Chang Liu, Xin Zhang, Qiuxiang Ou, Qiaojuan Li, Yan Li, Zhen Wang, Cuicui Liu, Xianghua Wu, Huijie Wang, Hui Yu, Si Sun, Xinmin Zhao, Zhihuang Hu, Yao Zhang, Ying Lin, Bo Yu, Shenglin Huang, Jialei Wang

Cancer Sci. 2023 Jul; 114(7): 2774–2786. Published online 2023 Apr 20. doi: 10.1111/cas.15804

PMCID:: PMC10323081

Abstract Article PDF–3.7M

Select item 95197312.

The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma

Marie-Léa Gauci, Jérôme Giustiniani, Clémence Lepelletier, Christian Garbar, Nicolas Thonnart, Nicolas Dumaz, Arnaud Foussat, Céleste Lebbé, Armand Bensussan, Anne Marie-Cardine

Cancer Immunol Immunother. 2022 Nov; 71(11): 2731–2742. Published online 2022 Apr 15. doi: 10.1007/s00262-022-03199-0

PMCID:: PMC9519731

Abstract Article PDF–1.1M

Select item 94694713.

CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression

Zheng Sun, Yidi Li, Zining Zhang, Yajing Fu, Xiaoxu Han, Qinghai Hu, Haibo Ding, Hong Shang, Yongjun Jiang

Front Immunol. 2022; 13: 854432. Published online 2022 Aug 19. doi: 10.3389/fimmu.2022.854432

PMCID:: PMC9469471

Abstract Article PDF–9.3M

Select item 82685074.

Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study

Weiwei He, Jing Zhao, Xuerong Liu, Sheli Li, Kaida Mu, Jing Zhang, Jin-an Zhang

BMC Endocr Disord. 2021; 21: 148. Published online 2021 Jul 8. doi: 10.1186/s12902-021-00810-w

PMCID:: PMC8268507

Abstract Article PDF–559K

Select item 80989555.

Expanded antigen-experienced CD160⁺CD8⁺effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia

Najmeh Bozorgmehr, Isobel Okoye, Olaide Oyegbami, Lai Xu, Amelie Fontaine, Nanette Cox-Kennett, Loree M Larratt, Mark Hnatiuk, Andrei Fagarasanu, Joseph Brandwein, Anthea C Peters, Shokrollah Elahi

J Immunother Cancer. 2021; 9(4): e002189. Published online 2021 Apr 30. doi: 10.1136/jitc-2020-002189

PMCID:: PMC8098955

Abstract Article PDF–5.0M

Select item 74779516.

Structural Basis of CD160:HVEM Recognition

Weifeng Liu, Sarah C. Garrett, Elena V. Fedorov, Udupi A. Ramagopal, Scott J. Garforth, Jeffrey B. Bonanno, Steven C. Almo

Structure. Author manuscript; available in PMC 2020 Sep 8.

Published in final edited form as: Structure. 2019 Aug 6; 27(8): 1286–1295.e4. Published online 2019 Jun 20. doi: 10.1016/j.str.2019.05.010

PMCID:: PMC7477951

Abstract Article PDF–2.1M

Select item 52925917.

Differential and tumor-specific expression of CD160 in B-cell malignancies

Timothy W. Farren, Jerome Giustiniani, Feng-Ting Liu, Dimitris A. Tsitsikas, Marion G. Macey, James D. Cavenagh, Heather E. Oakervee, David Taussig, Adrian C. Newland, Maria Calaminici, Armand Bensussan, Michael Jenner, John G. Gribben, Samir G. Agrawal

Blood. 2011 Aug 25; 118(8): 2174–2183. Prepublished online 2011 Jun 28. doi: 10.1182/blood-2011-02-334326

PMCID:: PMC5292591

Abstract Article

Select item 44676748.

Increased CD160 expression on circulating natural killer cells in atherogenesis

Jin Zuo, Zhaoliang Shan, Lin Zhou, Jian Yu, Xiaopeng Liu, Yuan Gao

J Transl Med. 2015; 13: 188. Published online 2015 Jun 13. doi: 10.1186/s12967-015-0564-3

PMCID:: PMC4467674

Abstract Article PDF–2.5M

Select item 43144559.

Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

T W Farren, J Giustiniani, M Fanous, F Liu, M G Macey, F Wright, A Prentice, A Nathwani, S G Agrawal

Blood Cancer J. 2015 Jan; 5(1): e273. Published online 2015 Jan 23. doi: 10.1038/bcj.2014.92

PMCID:: PMC4314455

Abstract Article PDF–438K

Select item 416317310.

CD160 isoforms and regulation of CD4 and CD8 T-cell responses

Mohamed El-Far, Charles Pellerin, Louise Pilote, Jean-Francois Fortin, Ivan A D Lessard, Yoav Peretz, Elizabeth Wardrop, Patrick Salois, Richard C Bethell, Michael G Cordingley, George Kukolj

J Transl Med. 2014; 12: 217. Published online 2014 Sep 2. doi: 10.1186/s12967-014-0217-y

PMCID:: PMC4163173

Abstract Article PDF–2.2M

Select item 309235011.

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor

Sophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, Julie Tabiasco, Alexandra Provost, Muriel Golzio, Muhammad Zaeem Noman, Jérôme Giustiniani, Elisabeth Bellard, Stéphanie Brayer, Maryse Aguerre-Girr, Fabienne Meggetto, Sylvie Giuriato, François Malecaze, Stéphane Galiacy, Jean-Philippe Jaïs, Olivier Chose, Jean Kadouche, Salem Chouaib, Justin Teissié, Marc Abitbol, Armand Bensussan, Philippe Le Bouteiller

J Exp Med. 2011 May 9; 208(5): 973–986. doi: 10.1084/jem.20100810

PMCID:: PMC3092350

Abstract Article PDF–3.1M

Select item 4476212.

BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity.

A Bensussan, E Gluckman, S el Marsafy, V Schiavon, I G Mansur, J Dausset, L Boumsell, E Carosella

Proc Natl Acad Sci U S A. 1994 Sep 13; 91(19): 9136–9140. doi: 10.1073/pnas.91.19.9136

PMCID:: PMC44762

Summary Page Browse PDF–1.0M

Select item 753358013.

CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells

Linxia Zhang, Anli Zhang, Jun Xu, Chao Qiu, Lingyan Zhu, Chenli Qiu, Weihui Fu, Ying Wang, Lilin Ye, Yang-xin Fu, Chen Zhao, Xiaoyan Zhang, Jianqing Xu

Front Immunol. 2020; 11: 2188. Published online 2020 Sep 11. doi: 10.3389/fimmu.2020.02188

PMCID:: PMC7533580

Abstract Article PDF–3.8M

Select item 529259014.

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia

Feng-Ting Liu, Jerome Giustiniani, Timothy Farren, Li Jia, Armand Bensussan, John G. Gribben, Samir G. Agrawal

Blood. 2010 Apr 15; 115(15): 3079–3088. Prepublished online 2010 Feb 17. doi: 10.1182/blood-2009-08-239483

PMCID:: PMC5292590

Abstract Article

Select item 459183015.

Biased G_sVersus G_q Proteins and β-Arrestin Signaling in the NK1 Receptor Determined by Interactions in the Water Hydrogen Bond Network

Louise Valentin-Hansen, Thomas M. Frimurer, Jacek Mokrosinski, Nicholas D. Holliday, Thue W. Schwartz

J Biol Chem. 2015 Oct 2; 290(40): 24495–24508. Published online 2015 Aug 12. doi: 10.1074/jbc.M115.641944

PMCID:: PMC4591830

Abstract Article PDF–3.2M

Select item 370264616.

CD160 Activation by Herpesvirus Entry Mediator Augments Inflammatory Cytokine Production and Cytolytic Function by NK cells

John R. Šedý, Ryan L. Bjordahl, Vasileios Bekiaris, Matthew G. Macauley, Brian C. Ware, Paula S. Norris, Nell S. Lurain, Chris A. Benedict, Carl F. Ware

J Immunol. Author manuscript; available in PMC 2014 Jul 15.

Published in final edited form as: J Immunol. 2013 Jul 15; 191(2): 828–836. Published online 2013 Jun 12. doi: 10.4049/jimmunol.1300894

PMCID:: PMC3702646

Abstract Article PDF–1.2M

Select item 347240317.

Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation

Jérôme Giustiniani, Armand Bensussan, Anne Marie-Cardine

J Immunol. Author manuscript; available in PMC 2012 Oct 18.

Published in final edited form as: J Immunol. 2009 Jan; 182(1): 63–71. doi: 10.4049/jimmunol.182.1.63

PMCID:: PMC3472403

Abstract Article

Select item 342093018.

CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction

Yoav Peretz, Zhong He, Yu Shi, Bader Yassine-Diab, Jean-Philippe Goulet, Rebeka Bordi, Ali Filali-Mouhim, Jean-Baptiste Loubert, Mohamed El-Far, Franck P. Dupuy, Mohamed Rachid Boulassel, Cécile Tremblay, Jean-Pierre Routy, Nicole Bernard, Robert Balderas, Elias K. Haddad, Rafick-Pierre Sékaly

PLoS Pathog. 2012 Aug; 8(8): e1002840. Published online 2012 Aug 16. doi: 10.1371/journal.ppat.1002840

PMCID:: PMC3420930

Abstract Article PDF–668K

Select item 855883819.

HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160

Weifeng Liu, Ting-Fang Chou, Sarah C. Garrett-Thomson, Goo-Young Seo, Elena Fedorov, Udupi A. Ramagopal, Jeffrey B. Bonanno, Qingyang Wang, Kenneth Kim, Scott J. Garforth, Kiyokazu Kakugawa, Hilde Cheroutre, Mitchell Kronenberg, Steven C. Almo

J Exp Med. 2021 Dec 6; 218(12): e20211112. Published online 2021 Oct 28. doi: 10.1084/jem.20211112

PMCID:: PMC8558838

Abstract Article PDF–7.0M

Select item 13925220.

Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity

Philippe Le Bouteiller, Aliz Barakonyi, Jérome Giustiniani, Françoise Lenfant, Anne Marie-Cardine, Maryse Aguerre-Girr, Magali Rabot, Ivan Hilgert, Fathia Mami-Chouaib, Julie Tabiasco, Laurence Boumsell, Armand Bensussan

Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26): 16963–16968. Published online 2002 Dec 16. doi: 10.1073/pnas.012681099

PMCID:: PMC139252

Abstract Article PDF–261K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Gene

Items: 1 to 20 of 28

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity